<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.EmailStyle18
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri","sans-serif";}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1657877248;
mso-list-template-ids:1961144056;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link=blue vlink=purple><div class=WordSection1><p><b><u>Opioid Treatment and Policy Issues for the Criminal Justice System Webinar</u></b> <span style='color:#1F497D'><br></span>November 18, 2014. <span style='color:#1F497D'><br></span>2:00 pm EST<span style='color:#1F497D'>--</span>3:00<span style='color:#1F497D'> </span>pm EST. <span style='color:#1F497D'><br></span>Project Directors and any other staff are welcome (e.g. Clinical Supervisor, Evaluator, etc.). <span style='color:#1F497D'><o:p></o:p></span></p><p>There are a limited number of phone lines, so please call from the same location, if possible. <br> <br><b>During this webinar participants will learn:</b> <o:p></o:p></p><ul type=disc><li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1'>The benefits of MAT <o:p></o:p></li><li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1'>Medications for alcohol dependence and medications for opioid dependence <o:p></o:p></li><li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1'>Cost-effectiveness of drug treatment <o:p></o:p></li><li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1'>Duration of MAT treatment <o:p></o:p></li><li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1'>Methadone treatment today <o:p></o:p></li><li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1'>MAT knowledge, attitudes, and practices in drug court and reentry programs <o:p></o:p></li><li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1'>The legality of denying access to MAT in the criminal justice system <o:p></o:p></li><li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1'>Changing drug use patterns among patient admissions to the methadone treatment programs in the U.S. <o:p></o:p></li><li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo1'>New MAT Fact Sheet and other resources available to assist with MAT implementation<o:p></o:p></li></ul><p class=MsoNormal><b><u>JOIN THE WEBEX MEETING:</u></b> <br><b> </b> <br><b>Event address for attendees: </b><br><a href="http://cjjlist.jbsinternational.com/lists/lt.php?id=K0oHBVMDCF1PCVAMBEtQAlNV">https://jbsinternational.webex.com/jbsinternational/onstage/g.php?MTID=e3cd0bba18026c5857d7e43e671c19e3f</a> <br><b>Event password:</b> blue <br> <br><b>Call-in toll-free number:</b> 1-877-668-4490 <br><b>Access code:</b> 572 696 427 <br> <br>If you have any problems joining, please send an email to Nathan Gilbert (<a href="mailto:nathgilb@cisco.com">nathgilb@cisco.com</a>) <br> <br><b><u>IMPORTANT NOTICE:</u></b> Please note that this WebEx service allows audio and other information sent during the session to be recorded, which may be discoverable in a legal matter. By joining this session, you automatically consent to such recordings. If you do not consent to being recorded, discuss your concerns with the host or do not join the session. <br> <br>Sincerely, <br> <br><b>Kenneth W. Robertson</b> <br>Team Leader, Criminal Justice Grants <br>Targeted Populations Branch <br>Division of Systems Improvement/CSAT <br>Substance Abuse and Mental Health Services Administration <br>1 Choke Cherry Road <br>Room 5-1001 <br>Rockville, MD 20857 <br>Ph: 240-276-1621 <br>F: 240-276-2970 <br>Em: <a href="mailto:kenneth.robertson@samhsa.hhs.gov">kenneth.robertson@samhsa.hhs.gov</a> <o:p></o:p></p><p> <o:p></o:p></p><p><br><br>-- <br><span style='font-size:7.5pt;font-family:"Arial","sans-serif"'>powered by </span><a href="http://www.phplist.com/" target="_blank"><span style='font-size:7.5pt;font-family:"Arial","sans-serif"'>phplist</span></a><span style='font-size:7.5pt;font-family:"Arial","sans-serif"'> v 2.10.19, © </span><a href="http://cjjlist.jbsinternational.com/lists/lt.php?id=K0oHBVMDCFxPCVAMBEtQAlNV" target="_blank"><span style='font-size:7.5pt;font-family:"Arial","sans-serif"'>phpList ltd</span></a> <o:p></o:p></p></div></body></html>